Real World Experience in Heart Failure With Reduced Ejection Fraction (HFrEF) Patients Treated With sAc/vaL.
Condition: Heart Failure Intervention: Drug: Sacubitril/Valsartan Sponsor: Novartis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2022 Category: Research Source Type: clinical trials